These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Association of angiotensin-converting enzyme DD genotype with 24-h blood pressure abnormalities in normoalbuminuric children and adolescents with Type 1 diabetes. Barkai L, Soós A, Vámosi I. Diabet Med; 2005 Aug; 22(8):1054-9. PubMed ID: 16026372 [Abstract] [Full Text] [Related]
26. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene in myocardial infarction survivors. Hubacek JA, Pitha J, Podrapská I, Sochman J, Adámková V, Lánská V, Poledne R. Med Sci Monit; 2000 Aug; 6(3):503-6. PubMed ID: 11208361 [Abstract] [Full Text] [Related]
27. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study. Ay C, Bencur P, Vormittag R, Sailer T, Jungbauer C, Vukovich T, Mannhalter C, Pabinger I. Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801 [Abstract] [Full Text] [Related]
32. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors]. Rugale C, du Cailar G, Ribstein J, Mimran A. Arch Mal Coeur Vaiss; 2003 Feb; 96(7-8):772-5. PubMed ID: 12945221 [Abstract] [Full Text] [Related]
33. Angiotensin converting enzyme insertion/deletion polymorphism does not influence postcardiac transplantation hypertension onset or progression. Fildes JE, Walker AH, Densem CG, Deiraniya AK, Hutchinson IV, Leonard CT, Yonan N. J Heart Lung Transplant; 2005 Apr; 24(4):406-10. PubMed ID: 15797740 [Abstract] [Full Text] [Related]
34. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene. Takahashi T, Morimoto S, Okaishi K, Kanda T, Nakahashi T, Okuro M, Murai H, Nishimura Y, Iwai K, Matsumoto M. Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861 [Abstract] [Full Text] [Related]
35. Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension. Tascilar N, Dursun A, Ankarali H, Mungan G, Ekem S, Baris S. J Neurol Sci; 2009 Oct 15; 285(1-2):137-41. PubMed ID: 19596363 [Abstract] [Full Text] [Related]
36. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis]. Kutyrina IM, Tareeva IE, Nosikov VV, Kamyshova ES, Gorashko NM, Chistiakov DA, Okonova EB, Troepol'skaia OV. Ter Arkh; 1999 Oct 15; 71(6):30-4. PubMed ID: 10420452 [Abstract] [Full Text] [Related]
37. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension. Makris TK, Stavroulakis GA, Dafni UG, Gialeraki AE, Krespi PG, Hatzizacharias AN, Tsoukala CG, Vythoulkas JS, Kyriakidis MK. Am Heart J; 2000 Nov 15; 140(5):760-5. PubMed ID: 11054622 [Abstract] [Full Text] [Related]
39. Angiotensin converting enzyme insertion/deletion genetic polymorphism: its impact on renal function in critically ill patients. du Cheyron D, Fradin S, Ramakers M, Terzi N, Guillotin D, Bouchet B, Daubin C, Charbonneau P. Crit Care Med; 2008 Dec 15; 36(12):3178-83. PubMed ID: 19020433 [Abstract] [Full Text] [Related]